Brammer Bio to set up new plant in Norton, Massachusetts

pharmafile | August 12, 2019 | News story | Sales and Marketing Brammer Bio, Massachusetts, US, norton, pharma 

Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts.

The Thermo Fisher subsidiary plans to employ 300 staff in its new Norton plant by 2021.

While the project is still in the preliminary stages, the cell and gene therapy firm plans to fund the new plant with tax increment financing (TIF), a public financing method used for redevelopment.

Brammer currently employs around 600 people in various locations, so will be increasing its stff by 50%.

In recent years Alnylam Pharmaceuticals also set up a $200 million plant in Norton’s industrial park.

Louis Goss

Related Content

Expansion for first FDA-approved video game for ADHD treatment

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the …

New warning added to J&J vaccine in US

The FDA has made the decision to add a warning to the fact sheet for …


CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab

Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use …

Latest content